Valbiotis Announces the Signature of a Research Partnership in Intestinal Microbiota With the MEDIS Unit From the Clermont Auvergne University
This is an innovative angle, in line with our research and development strategy.
- This is an innovative angle, in line with our research and development strategy.
- The MIMETiv project, which will benefit from the combined expertise of the MEDIS Unit and Valbiotis, will take place in two stages.
- Valbiotis considers that these projections are based on rational hypotheses and the information available to Valbiotis at the present time.
- 1MIMETiv: Microbiote intestinal et maladies mtaboliques chez lHomme (Intestinal microbiota and metabolic diseases in humans): a unique in vitro digestive system to catalyze the development of innovative nutritional strategies.